Total Funding
71
74
Total FundingSeed raised
Growth Score
32 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
172201
Cellaria provides cancer research, patient testing, and treatment development.
- David Deems: CEO & President&Founder
- Dmitry Shvartsman: Chief Technology Officer
About the Company
Cellaria creates high-quality, next-generation in vitro disease models that reflect the unique nature of a patient’s biology. All of our models begin with tissue from a patient, capturing clinically relevant details that inform model characterization.
